Authors: MANZONE H BILLINGS PC CUMMINGS WN FELDMAN R CLARK LC ODELL CS HORAN AM ATIBA JO MEYSKENS FL KENNEDY AR

Citation: H. Manzone et al., LEVELS OF PROTEOLYTIC ACTIVITIES AS INTERMEDIATE MARKER END-POINTS INORAL CARCINOGENESIS, Cancer epidemiology, biomarkers & prevention, 4(5), 1995, pp. 521-527

Authors: KENNEDY AR MANZONE H

Citation: Ar. Kennedy et H. Manzone, EFFECTS OF PROTEASE INHIBITORS ON LEVELS OF PROTEOLYTIC ACTIVITY IN NORMAL AND PREMALIGNANT CELLS AND TISSUES, Journal of cellular biochemistry, 1995, pp. 188-194

Authors: WAN XS KOCH CJ LORD EM MANZONE H BILLINGS PC DONAHUE JJ ODELL CS MILLER JH SCHMIDT NA KENNEDY AR

Citation: Xs. Wan et al., MONOCLONAL-ANTIBODIES DIFFERENTIALLY REACTIVE WITH NATIVE AND REDUCTIVELY MODIFIED BOWMAN-BIRK PROTEASE INHIBITOR, Journal of immunological methods, 180(1), 1995, pp. 117-130

Authors: LAMBRIS JD PAPPAS J MAVROIDIS M WANG Y MANZONE H SCHWAGER J DUPASQUIER L SILIBOVSKY R

Citation: Jd. Lambris et al., THE 3RD COMPONENT OF XENOPUS COMPLEMENT - CDNA CLONING, STRUCTURAL AND FUNCTIONAL-ANALYSIS, AND EVIDENCE FOR AN ALTERNATIVE C3 TRANSCRIPT (VOL 25, PG 572, 1995), European Journal of Immunology, 25(5), 1995, pp. 1485-1485

Authors: LAMBRIS JD PAPPAS J MAVROIDIS M WANG Y MANZONE H SWAGER J DUPASQUIER L SILIBOVSKY R

Citation: Jd. Lambris et al., THE 3RD COMPONENT OF XENOPUS COMPLEMENT - CDNA CLONING, STRUCTURAL AND FUNCTIONAL-ANALYSIS, AND EVIDENCE FOR AN ALTERNATE C3 TRANSCRIPT, European Journal of Immunology, 25(2), 1995, pp. 572-578